MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$1,418M
(172.38%↑ Y/Y)
Impairment of long-lived
assets and assets held...
$1,028M
(-19.37%↓ Y/Y)
Beneficial interest
collected in exchange for...
$1,214M
(-5.96%↓ Y/Y)
Depreciation and
amortization
$1,002M
(-5.38%↓ Y/Y)
Stock-based compensation
$157M
(27.64%↑ Y/Y)
Other items, net
$81M
(-85.54%↓ Y/Y)
Proceeds from sale of
investments
$42M
(5.00%↑ Y/Y)
Proceeds from sale of
business and long lived...
$34M
(-20.93%↓ Y/Y)
Other investing
activities
-$5M
(-150.00%↓ Y/Y)
Net cash provided by
(used in) operating...
$1,649M
(32.24%↑ Y/Y)
Net cash provided by
(used in) investing...
$737M
(-6.94%↓ Y/Y)
Translation adjustment on
cash, cash...
$21M
(112.07%↑ Y/Y)
Canceled cashflow
$2,037M
Canceled cashflow
$558M
Net change in cash,
cash equivalents and...
$256M
(245.95%↑ Y/Y)
Canceled cashflow
$2,151M
Net change in
operating assets and...
$1,366M
(214.02%↑ Y/Y)
Deferred income taxes net
and uncertain tax...
-$671M
(-5.84%↓ Y/Y)
Proceeds from senior
notes, net of issuance...
$2,298M
Other financing
activities
$41M
(612.50%↑ Y/Y)
Purchases of property,
plant and equipment...
$501M
(0.60%↑ Y/Y)
Purchases of investments
and other assets
$57M
(-19.72%↓ Y/Y)
Net cash provided by
(used in) financing...
-$2,151M
(-20.10%↓ Y/Y)
Canceled cashflow
$2,339M
Repayment of senior notes
and loans and other...
$4,112M
(150.58%↑ Y/Y)
Dividends paid to
redeemable and...
-$340M
(-335.90%↓ Y/Y)
Purchase of shares from
redeemable and...
-$38M
(40.63%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)